Regenxbio
RGNX
159 hedge funds and large institutions have $610M invested in Regenxbio in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 62 increasing their positions, 51 reducing their positions, and 25 closing their positions.
117% more call options, than puts
Call options by funds: $4.47M | Put options by funds: $2.06M
22% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 51
1.14% less ownership
Funds ownership: 85.4% → 84.26% (-1.1%)
5% less funds holding
Funds holding: 167 → 159 (-8)
18% less capital invested
Capital invested by funds: $742M → $610M (-$132M)
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$9.92M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.33M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.46M |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$1.32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$4.69M |
| 2 |
BlackRock
New York
|
-$4.39M |
| 3 |
SGL
Sonic GP LLC
Honolulu,
Hawaii
|
-$4.08M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.54M |
| 5 |
WM
WS Management
Jacksonville,
Florida
|
-$3.22M |
RGNX Hedge Fund Activity: Q3 2023 in Review
159 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2023, worth a combined $610M — down 18% from $742M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of RGNX and 17 opened new positions — a net loss of 8 holders — while 51 trimmed existing stakes and 62 added.
The largest buyer was Redmile Group, adding an estimated $9.92M. The largest seller was State Street, cutting an estimated $4.69M.
- 159 institutional investors held Regenxbio (RGNX) as of Q3 2023, down from 167 in Q2 2023.
- Funds reported $610M of Regenxbio stock for Q3 2023, down 18% quarter-over-quarter.
- 17 funds opened new Regenxbio positions in Q3 2023 and 25 closed out, a net change of -8 holders.
- The largest Regenxbio buyer in Q3 2023 was Redmile Group, an estimated $9.92M added.
- The largest Regenxbio seller in Q3 2023 was State Street, an estimated $4.69M sold.
Based on aggregated 13F filings for Q3 2023.